EligibleTrials

The Effect of Therapy Combination in PCOS With Dlbs 3233

Recruiting · NCT07403201 · Interventional (participants receive a specific treatment) · Lead sponsor: Inlacinpenelitian

View the official record on ClinicalTrials.gov →
PCOS

Interventions studied

dlbs 3233 , clomifen citrat

What this trial is about

The effect of combination therapy dlbs 3233 and clomifen citrate vs clomifen citrate on homa ir, maturation follicle, and menstrual cycle in PCOS cases at Muhammadiyah Asri Medical Center Hospital

Who can take part

Age range
Up to 45 Years
Sex
Female
Healthy volunteers
No - a diagnosis or condition is required
Phase
Early Phase 1
Study type
Interventional (participants receive a specific treatment)

Inclusion criteria

Exclusion criteria

Where it is running

1 location listed.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.